Search filters

List of works by Judith Clancy Keen

A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.

scientific article published in October 2003

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells.

scientific article published on 23 September 2008

Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.

scientific article published on 9 December 2004

Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells.

scientific article

Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability.

scientific article published on 17 June 2005

The 'RNA-binding ome': future implications for chemotherapeutic efficacy

scientific article published on 01 November 2009

The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines.

scientific article

The biology of breast carcinoma

scientific article

The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.

scientific article published on June 2009

Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity.

scientific article

Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR.

scientific article published on 21 September 2007

pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs

scientific article

Paulina is supported by:

About Paulina

Help